ACTIVATION GP (09919) releases interim results, with profit attributable to shareholders amounting to 22.879 million yuan.
Aide Weixuan Group (09919) announced its interim results for the six months ending June 30, 2026. During this period, the Group achieved revenue of 287 million yuan (RMB); profit attributable to owners of the parent company was 22.879 million yuan; basic earnings per share were 3.07 cents. An interim dividend of 1.8 Hong Kong cents per share is proposed.
ACTIVATION GP (09919) released its interim results for the six months ending June 30, 2026, reporting revenue of RMB 287 million; profit attributable to equity holders of the parent company was RMB 22.879 million; basic earnings per share were 3.07 cents. A mid-term dividend of 1.8 Hong Kong cents per share is proposed.
The Group is a leading pan-fashion brand marketing group in Greater China, primarily focusing on operating (i) experience marketing; (ii) digital marketing and promotion; and (iii) intellectual property (IP) expansion services in the Greater China region. The Group has accumulated over 550 clients from globally renowned brands, including (i) well-known mid- to high-end fashion brands; (ii) well-known mid- to high-end automotive brands; and (iii) high-end Chinese brands. According to data from Insights Industry Consulting Ltd., the Group remains the largest provider of high-end luxury brand experience marketing services in Greater China, with a market share of 13.9% projected for 2025.
The Group maintains a robust cash position. In the second half of the year, management will focus on project profitability management, resource allocation efficiency, and the prudent expansion of high-potential areas such as sportswear and beauty skincare, while continuing to serve core high-end brand clients.
Related Articles

TSAKER NE (01986) spent HKD 35,600 on August 24 to repurchase 39,000 shares.

InnoCare Pharma (09969) announced its interim results, with adjusted profits of approximately 277 million yuan, marking a year-on-year turnaround from losses to profits.

SINOPEC CORP (00386) spent approximately HKD 124,500 to repurchase 28,000 shares on August 24.
TSAKER NE (01986) spent HKD 35,600 on August 24 to repurchase 39,000 shares.

InnoCare Pharma (09969) announced its interim results, with adjusted profits of approximately 277 million yuan, marking a year-on-year turnaround from losses to profits.

SINOPEC CORP (00386) spent approximately HKD 124,500 to repurchase 28,000 shares on August 24.

RECOMMEND





